NCT05039632 2026-02-06Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid MalignanciesM.D. Anderson Cancer CenterPhase 1/2 Recruiting40 enrolled